Aerovate Therapeutics, Inc. (AVTE)
NASDAQ: AVTE · Real-Time Price · USD
2.510
+0.005 (0.20%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Aerovate Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Market Capitalization
7377626721288-
Upgrade
Market Cap Growth
-87.78%-87.78%-13.15%150.50%--
Upgrade
Enterprise Value
-5-12492580108-
Upgrade
Last Close Price
2.512.6522.6329.3011.79-
Upgrade
PB Ratio
0.951.005.725.691.67-
Upgrade
P/TBV Ratio
1.001.005.725.691.67-
Upgrade
Debt / Equity Ratio
0.010.010.010.010.00-
Upgrade
Quick Ratio
20.5420.546.9416.6165.642.58
Upgrade
Current Ratio
20.9320.937.0416.9068.372.64
Upgrade
Return on Equity (ROE)
-74.91%-74.91%-63.95%-34.44%-26.19%-582.84%
Upgrade
Return on Assets (ROA)
-44.88%-44.88%-38.73%-21.42%-15.98%-135.03%
Upgrade
Return on Capital (ROIC)
-49.87%-49.87%-42.76%-22.12%-16.36%-191.64%
Upgrade
Earnings Yield
-95.14%-91.00%-12.06%-7.14%-7.98%-
Upgrade
FCF Yield
-97.28%-93.05%-9.09%-5.45%-9.58%-
Upgrade
Buyback Yield / Dilution
-8.55%-8.55%-7.60%-99.06%-4975.15%-0.32%
Upgrade
Updated Feb 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q